MREO
Mereo BioPharma Group plc
Key Financials
Net Income
$-41878000
↑ 3.2%
Operating Income
$-40107000
↑ 15.3%
Revenue
$500000
↑ Infinity%
EPS (Diluted)
$-0.05
↑ 16.7%
Total Assets
$45.9M
↓ 39.9%
Total Liabilities
$5.0M
↓ 67.6%
Operating Cash Flow
$-30971000.00
↑ 5.7%
Cash & Equivalents
$41.0M
↓ 41.3%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| SCHEDULE 13G/A | 5/15/2026 | View on SEC |
| SCHEDULE 13G | 5/14/2026 | View on SEC |
| 8-K | 5/14/2026 | View on SEC |
| 8-K/A | 5/12/2026 | View on SEC |
| 10-Q | 5/12/2026 | View on SEC |
| 8-K | 5/12/2026 | View on SEC |
| ARS | 4/9/2026 | View on SEC |
| DEF 14A | 4/9/2026 | View on SEC |
| PRE 14A | 3/27/2026 | View on SEC |
| 8-K | 3/27/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | MREO |
| Company Name | Mereo BioPharma Group plc |
| CIK | 1719714 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | X0 |
| Phone | 4403330237300 |